血栓性静脉胸廓出口综合征后的血栓后综合征
这项回顾性研究纳入2014至2024年单中心50例血栓性静脉胸廓出口综合征患者,按末次随访改良Villalta评分分为<5分(28例)和≥5分(22例)。
要点
- 静脉通畅性与血栓后综合征风险相关,持续性锁骨下静脉闭塞更常见于Villalta≥5分者。
- 单纯急性期血管内治疗未联合胸廓出口手术与血栓后综合征风险升高相关。
- 血管内治疗联合胸廓出口手术未显示与血栓后综合征风险相关。
核心结论
- 静脉通畅在血栓性静脉胸廓出口综合征临床病程中起核心作用,持续性锁骨下静脉闭塞与血栓后综合征风险升高相关。
- 单纯急性期血管内治疗与血栓后综合征风险的关联不支持该策略有明确获益。
- 血管内治疗联合胸廓出口手术可能降低血栓后综合征风险。
研究设计与样本
- 回顾性研究纳入2014至2024年大学医院血管医学科连续诊断的血栓性静脉胸廓出口综合征患者50例。
- 按末次随访改良Villalta评分分为<5分(28例)与≥5分(22例),由同一医师标准化评估。
- 采用单变量和多变量logistic回归,并以Firth惩罚似然法处理有限事件数。
关键数值与推荐
- 血栓后综合征定义为末次随访改良Villalta评分≥5分。
临床怎么用
- 对血栓性静脉胸廓出口综合征患者应关注随访静脉通畅性,持续性锁骨下静脉闭塞提示血栓后综合征风险升高。
- 急性期单纯血管内治疗而未联合胸廓出口手术的策略需谨慎评估,该研究不支持其明确获益。
- 血管内治疗联合胸廓出口手术可能降低血栓后综合征风险,但需进一步研究验证。
局限性
- 回顾性单中心设计,样本量有限(50例),事件数少。
- 采用Firth惩罚似然法处理有限事件数,结果需谨慎解读。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thrombotic venous thoracic outlet syndrome (T-vTOS), including Paget-Schrotter syndrome, is a rare form of upper extremity deep vein thrombosis that mainly affects young, active individuals. Its optimal management remains debated, and the medium-term outcomes have been poorly documented. METHODS: This retrospective study included consecutive patients diagnosed with T-vTOS at the vascular medicine department of a university hospital between 2014 and 2024. Patients were stratified according to the presence of post-thrombotic syndrome (PTS) using the modified Villalta score at the last follow-up (<5 vs ≥5). Clinical characteristics, therapeutic strategies, and outcomes were systematically assessed through a standardized evaluation performed by the same physician. Univariable and multivariable logistic regression analyses, using Firth's penalized-likelihood method to account for the limited number of events, were performed to identify the factors associated with PTS. RESULTS: A total of 50 patients were included: 28 with a Villalta score of <5 and 22 with a Villalta score of ≥5 at the last follow-up. Patients with a Villalta score of <5 achieved higher rates of complete subclavian vein recanalization at follow-up (63% vs 32%; P = .045) and were less likely to have persistent subclavian vein occlusion (26% vs 59%; P = .023). Patients with a Villalta score of ≥5 more often required prolonged anticoagulation (73% vs 29%; P = .004) and more frequently underwent acute-phase endovascular treatment (36% vs 4%; P = .007). In the multivariable analysis, endovascular treatment alone without thoracic outlet surgery was associated with an increased risk of PTS (odds ratio, 10.6; 95% confidence interval, 1.15, 98.09) (P = .037), whereas no association was found between the risk of PTS and patients who had undergone both endovascular treatment and TOS surgery (odds ratio 1.3; 95% confidence interval, 0.26, 6.87) (P = .736). CONCLUSIONS: This study highlights the central role of venous patency in the clinical course of T-vTOS, with persistent subclavian vein occlusion associated with an increased risk of PTS. The association observed between acute-phase endovascular treatment alone and the risk of PTS does not support a clear benefit of this strategy. However, endovascular therapy in conjunction with surgical decompression of the thoracic outlet may reduce the risk of PTS.
引用
- Benhalima S, Gautier G, Douane F, et al. Post-thrombotic syndrome after thrombotic venous thoracic outlet syndrome. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42855073. doi:10.1016/j.jvsv.2026.102639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。